Navigation Links
Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
Date:1/24/2013

December 3120122011Cash flows from operating activities:  Net income$
94,732$
32,189  Adjustments to reconcile net income to net cash provided byoperating activities:Depreciation and amortization117,708105,214Non-cash impairment charges41,73612,119Non-cash compensation expense associated with employee benefitand stock compensation plans40,75940,057Deferred income tax benefit(8,404)(6,128)Gain on sale of investment(1,459)-Loss on sale of business169-Loss on disposal of property and equipment1,1811,618Equity investee earnings(17)(480)Changes in operating assets and liabilities, net of businesses soldand acquired:Accounts receivable(28,541)(50,754)Unbilled services(23,419)(23,366)Inventory10,9188,226Accounts payable(1,963)2,297Accrued liabilities8,20556,409Unearned revenue54,99815,909Income taxes(10,522)(21,070)Other assets and liabilities, net(35,920)(28,762)Net cash provided by operating activities260,161243,478Cash flows from investing activities:  Capital expenditures(151,679)(134,633)  Proceeds from sale of investment4,682-  Other, net1,017(219)Net cash used in investing activities(145,980)(134,852)Cash flows from financing activities:  Net borrowings (repayments) under revolving credit facility290,000(5,000)  Repayments under long-term debt-(97,500)  Stock issued under employee stock purchase and option plans13,7729,325  Purchase of treasury stock(323,773)(8,810)Net cash used in financing activities(20,001)(101,985)Effect of exchange rate changes on cash9,5415,239Net change in cash and cash equivalents103,72111,880Cash and cash equivalents, beginning of period389,103377,223Cash and cash equivalents, end of period$
492,824$
389,103 COVANCE INC.GAAP to Pro Forma ReconciliationQ4 2012(Dollars in thousands, except per share data)(UNAUDITED)AdjustmentsGAAP Restructuring Activities (1)Other
Items (2)Operating Results at Sites Wound-Down (3)Pro FormaNet revenues$
5
'/>"/>
SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
2. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
3. Covance to Present at the Morgan Stanley Global Healthcare Conference
4. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
5. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
10. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
11. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 1, 2015 Trinity Biotech plc (Nasdaq: ... of diagnostic products for the point-of-care and clinical ... Limited, its wholly-owned subsidiary (the "Issuer"), intends to ... million aggregate principal amount of Exchangeable Senior Notes ... institutional buyers pursuant to Rule 144A under the ...
(Date:4/1/2015)... 1, 2015  Pittman Motors has significantly expanded ... PLG42K, PLG42S, PLG52, and PLG63 planetary gearboxes. These ... brushless DC motors and complement Pittman,s existing spur ... 35 standard motor-gearbox family combinations to the Pittman ... high torque loads with excellent efficiency and are ...
(Date:4/1/2015)... MOUNTAIN VIEW, Calif. , April 1, ... ) announces that it has signed a definitive ... device company that develops, manufactures and sells minimally ... drainage of targeted areas within the gastrointestinal tract. ... The Xlumena portfolio includes the ...
Breaking Medicine Technology:Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 2Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 4Pittman Motors Expands PLG Planetary Gearbox Offering 2Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5
... Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: ... specializing in the development, manufacturing, and marketing of ... that Shanghai Celgen Bio-Pharmaceutical Co., Ltd. ("Shanghai Celgen") ... interest, has received new drug registration approval for ...
... Cempra Pharmaceuticals, a developer of differentiated antibiotics, ... (IV) solithromycin demonstrates excellent tolerability and ... up to 800 mg.  Oral administration of solithromycin ... 1 studies.  The presentation will be at the ...
Cached Medicine Technology:Simcere Announces Recent Progress of Qiangke's Registration 2Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 2Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 3Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 4Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 5Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 6Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 7
(Date:4/1/2015)... NTOCC today launches the Knowledge & ... that seek to improve care transitions and positively impact ... to bring light to tools or resources that align ... the healthcare industry through the promotion of public policy, ... Following that vision, the Knowledge & Resource Center serves ...
(Date:4/1/2015)... After a particularly harsh winter, many roads ... lead to costly damage, so Amica Insurance has ... the following suggestions from AAA: , , ... inflated to the manufacturer’s recommended levels. , ... and uneven tire wear can be signs of bad shocks ...
(Date:4/1/2015)... April 01, 2015 The Pennsylvania Court ... lawsuits ( http://www.risperdallawsuit2014.com/ ) has scheduled a meeting ... the Philadelphia Court of Common Pleas, the meeting will ... Hall. Court records indicate that the proceeding will address ... of Risperdal users who experienced gynecomastia (male breast growth) ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 EAGAN, Minn. ... Minnesota and its family of companies (Blue Cross) today ... out the year with net income of $61.5 million, ... losses. The organization reported a net operating loss of ... a negative operating margin of one-tenth of one percent ...
(Date:4/1/2015)... Parents of teenaged and adolescent children ... the latest post discusses Teen Violence Related to Substance ... Dating Violence Awareness Month, the substance abuse treatment center ... help parents identify if there may be problems with ... drugs or alcohol. , “People learn how to establish ...
Breaking Medicine News(10 mins):Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 3Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2
... ... Saunders for Chairman of the President,s Council on Physical Fitness & Sports ... will be held February 10 at 2:35 PM on the Senate Floor ... appointment to chairman of the President,s Council on Physical Fitness & Sports ...
... ... On WaveMaker Cloud Development Platform and Amazon EC2 , ... San Francisco, CA (PRWEB) -- WaveMaker Software™, the ... using WaveMaker and Amazon EC2. This application makes malaria research data available through a ...
... researchers say , , MONDAY, Feb. 8 (HealthDay News) ... and the antidepressant Paxil may increase their risk of ... , "Paxil can deprive women of the benefit of ... tamoxifen for a long time," said lead researcher Dr. ...
... , Feb. 8 Since 2003, Amway has mobilized ... better lives for children in need. , Now in its ... Children has improved the lives of an estimated 7 million children ... global impact. , Employees and distributors alike have volunteered more ...
... Ewing sarcoma: potential new drug target? Ewing ... that affects children and young adults. The protein CD99 is ... in the disease is unknown. Now, Katia Scotlandi and colleagues, ... have identified a crucial role for CD99 in the development ...
... occurs in the corneas of mountain climbers, but does ... to 6,300 meters (about 20,670 feet), according to a ... Ophthalmology, one of the JAMA/Archives journals. "High-altitude ... the authors write as background information in the article. ...
Cached Medicine News:Health News:Senator Janis Lee Sponsors Senate Resolution Supporting Kevin Saunders for Chairman of the President's Council on Physical Fitness & Sports 2Health News:Senator Janis Lee Sponsors Senate Resolution Supporting Kevin Saunders for Chairman of the President's Council on Physical Fitness & Sports 3Health News:Senator Janis Lee Sponsors Senate Resolution Supporting Kevin Saunders for Chairman of the President's Council on Physical Fitness & Sports 4Health News:MARA Fights Malaria With WaveMaker and Amazon Web Services 2Health News:MARA Fights Malaria With WaveMaker and Amazon Web Services 3Health News:MARA Fights Malaria With WaveMaker and Amazon Web Services 4Health News:Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer 2Health News:Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer 3Health News:Amway One by One Campaign for Children Reaches 7 Million Kids 2Health News:Amway One by One Campaign for Children Reaches 7 Million Kids 3Health News:JCI online early table of contents: Feb. 8, 2010 2Health News:JCI online early table of contents: Feb. 8, 2010 3Health News:JCI online early table of contents: Feb. 8, 2010 4Health News:JCI online early table of contents: Feb. 8, 2010 5Health News:JCI online early table of contents: Feb. 8, 2010 6Health News:High-altitude climbs may cause corneal swelling, but do not appear to affect vision 2
... monitors and controls patient temperature primarily in ... surgery, trauma, or other medical conditions. The ... provided from a patient temperature probe. Circulating ... and 42C (107.6F) to achieve a preset ...
... The Littmann Electronic Stethoscope Model 4100WS ... (ANR) technology allowing you to reduce ambient ... without eliminating critical body sounds. Three frequency ... lung, and other body sounds: Bell (20-200 ...
... The OmniMD orthopedics EMR addresses the vast ... specific EMR includes clinically-defined templates for common ... review of systems. The system also includes ... are used to capture accurate charges and ...
Intrinsic Dual Chamber ICD With MVP Mode (Managed Ventricular Pacing). MVP promotes intrinsic conduction and is clinically proven to reduce unnecessary right ventricular (RV) pacing to approximately...
Medicine Products: